癌症之外的 CAR 工程化细胞治疗:重编程纤维化和免疫介导炎症 CAR-Engineered Cell Therapies Beyond Cancer: Reprogramming Fibrosis and Immune-Mediated Inflammation. PubMed 2026/08/30 发表Adv Sci (Weinh)Q1 · IF 14.1(JCR 2025) 靶点:BCMA技术:CAR-T技术:CAR-NK技术:NK 细胞血液系统恶性肿瘤地区:中国
多发性骨髓瘤 CAR-NK 细胞治疗的最新进展:细胞来源与靶抗原的综合综述 State of the Art of CAR-NK Cell Therapy in Multiple Myeloma: A Comprehensive Review of Cell Sources and Target Antigens. PubMed 2025/11/20 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 靶点:CD38靶点:CD70靶点:BCMA技术:CAR-T技术:CAR-NK技术:NK 细胞
CAR-T 细胞治疗血液系统恶性肿瘤的进展 Progress on CAR-T cell therapy for hematological malignancies. PubMed 2022/04/25 发表Zhejiang Da Xue Xue Bao Yi Xue Ban 靶点:CD19靶点:CD7靶点:BCMA技术:CAR-T技术:CAR-NK技术:NK 细胞